Literature DB >> 23402939

The effects of aflatoxin B1 on transporters and steroid metabolizing enzymes in JEG-3 cells.

Pasi Huuskonen1, Päivi Myllynen, Markus Storvik, Markku Pasanen.   

Abstract

Effects of 96 h aflatoxin B1 (AFB1) exposure at concentrations from 0.2 μM to 6 μM on the mRNA and protein expression levels of the following transporters ABCB1/B4, ABCC1, ABCC2, ABCG2, OAT4 and the mRNA expression of steroid-metabolizing enzymes CYP1A1, CYP19A1, HSD3B1 and HSD17B1, and conjugating enzyme family UGT1A were evaluated in trophoblastic JEG-3 cells. Statistically significant dose-dependent five-fold increases in the expression levels with ABCC2 and OAT4 were recorded at 2 and 6μM AFB1. Protein expression of ABCG2 was decreased dose-dependently with 0.2-6 μM AFB1. With the other transporters, only a trend of increased expression was observed. Analogously, a three-fold increase in the expressions of CYP19A1, HSD3B1, HSD17B1 and UGT1A-family were observed at 0.3 μM AFB1. When an inhibitor of CYP19A1, finrozole, was dosed simultaneously with AFB1, no increases in the transcripts of transporters or steroid hydroxylases or CYP19A1 were observed. This delayed increase in the expression levels - only after 96h incubations - may indicate that the response is due to a secondary metabolite of AFB1 or other secondary controlling cascades rather than the parent compound itself. In conclusion, AFB1 affected the placental steroid synthesizing, metabolizing and conjugating enzymes as well as the expression levels of several transporter proteins in JEG-3 cells. These alterations may lead to anomalies in the foetoplacental hormonal homeostasis.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23402939     DOI: 10.1016/j.toxlet.2013.01.015

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  7 in total

1.  Aflatoxin B1 targeted gene expression profiles in human placental primary trophoblast cells.

Authors:  Rami El-Dairi; Jaana Rysä; Markus Storvik; Markku Pasanen; Pasi Huuskonen
Journal:  Curr Res Toxicol       Date:  2022-07-04

2.  Evaluation of Toxicant-Associated Fatty Liver Disease and Liver Neoplastic Progress in Sprague-Dawley Rats Treated with Low Doses of Aflatoxin B1 Alone or in Combination with Extremely Low Frequency Electromagnetic Fields.

Authors:  Andrea Vornoli; Eva Tibaldi; Federica Gnudi; Daria Sgargi; Fabiana Manservisi; Fiorella Belpoggi; Francesco Tovoli; Daniele Mandrioli
Journal:  Toxins (Basel)       Date:  2022-05-03       Impact factor: 5.075

Review 3.  Engaging One Health for Non-Communicable Diseases in Africa: Perspective for Mycotoxins.

Authors:  Carina Ladeira; Chiara Frazzoli; Orish Ebere Orisakwe
Journal:  Front Public Health       Date:  2017-10-16

4.  Insights into Aflatoxin B1 Toxicity in Cattle: An In Vitro Whole-Transcriptomic Approach.

Authors:  Marianna Pauletto; Roberta Tolosi; Mery Giantin; Giorgia Guerra; Andrea Barbarossa; Anna Zaghini; Mauro Dacasto
Journal:  Toxins (Basel)       Date:  2020-06-29       Impact factor: 4.546

5.  Effect of aflatoxin B1 on blood serum oestradiol-17β and progesterone concentrations during the luteal phase and the synchronized oestrus of goats.

Authors:  Georgios D Kourousekos; Ekaterini K Theodosiadou; Aristotelis G Lymberopoulos; Sofia Belibasaki; Constantin Boscos
Journal:  Anim Reprod       Date:  2018-08-16       Impact factor: 1.807

Review 6.  Overview of Drug Transporters in Human Placenta.

Authors:  Michiko Yamashita; Udo R Markert
Journal:  Int J Mol Sci       Date:  2021-12-05       Impact factor: 5.923

7.  Does Bentonite Cause Cytotoxic and Whole-Transcriptomic Adverse Effects in Enterocytes When Used to Reduce Aflatoxin B1 Exposure?

Authors:  Greta Mucignat; Irene Bassan; Mery Giantin; Marianna Pauletto; Anisa Bardhi; Silvia Iori; Rosa Maria Lopparelli; Andrea Barbarossa; Anna Zaghini; Enrico Novelli; Mauro Dacasto
Journal:  Toxins (Basel)       Date:  2022-06-26       Impact factor: 5.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.